Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

NCT01310166 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

447

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: Fingolimod

Sponsor

Novartis Pharmaceuticals